Skip to main content
. 2024 Aug 20;14:19341. doi: 10.1038/s41598-024-70294-w

Figure 3.

Figure 3

Soluble Guanylyl Cyclase activation provides neuroprotection against vincristine-induced neurotoxicity. (A and B) Levels of cGMP in ES-MNs (A) and DRG neurons (B) shown as a proxy of sGC activation. Data are presented as mean ± SEM of 3 independent experiments (one-way ANOVA for A: **p = 0.0077, ****p < 0.0001 relative to DMSO treated cells. One-way ANOVA for B: DMSO vs VCR *p = 0.0468, DMSO vs SIN-1 **p = 0.0011, DMSO vs VCR + SIN-1 *p = 0.0363,). (C and D) Effect of ODQ treatment on SIN-1 neuroprotective activity in ES-MNs (C) and DRG neurons (D). Values are means ± SEM of 4 biological replicates (one-way ANOVA: ***p = 0.0002, ****p < 0.0001 relative to DMSO treated cells). (E and F) sGC activators SIN-1 and BAY 41–2272 protect neurite length against VCR in ES-MNs (E) and DRG neurons (F). Doses of compounds are expressed in a log scale. Values are means of six technical replicates; error bars are not shown for clarity. See also Figure S3.